Filing Details

Accession Number:
0001779453-19-000005
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-11-29 12:52:29
Reporting Period:
2019-05-09
Accepted Time:
2019-11-29 12:52:29
Original Submission Date:
2019-06-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662774 Cortexyme Inc. CRTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1779451 Chad Boeding One Lombard Street, Suite 200
San Francisco CA 94111
No No No Yes
1779453 Epiq Capital Group, Llc One Lombard Street, Suite 200
San Francisco CA 94111
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-10 4,350 $26.41 2,835,560 No 4 P Direct
Common Stock Acquisiton 2019-05-10 4,170 $27.58 2,839,730 No 4 P Indirect By Mr. Boeding as Trustee of Boeding Family Trust
Common Stock Acquisiton 2019-05-10 80 $27.05 2,839,810 No 4 P Indirect By Mr. Boeding as custodian for minor child
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Mr. Boeding as Trustee of Boeding Family Trust
No 4 P Indirect By Mr. Boeding as custodian for minor child
Footnotes
  1. The reporting persons are EPIQ Capital Group, LLC ("EPIQ") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS ("CTYM") and CTEPQ Partners LLC ("CTEPQ"). Together CTYM and CTEPQ beneficially own +10% of the common stock of the issuer. Mr. Boeding is the Managing Member of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group, and each reporting person expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended.
  2. Beneficially owned directly by Mr. Boeding.
  3. Subsequent to an amended Form 3 filed 11/29/2019, the reporting persons are hereby amending Form 4 filed 6/14/2019 to amend the reported amount of securities beneficially owned for each transaction reported in Table 1.